# Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways

**Authors:** Zhaohui Wang, Zhi Chen, Bingsheng Li, Bo Zhang, Yongchao Du, Yuhang Liu, Yao He, Xiang Chen

PMC · DOI: 10.1080/13880209.2020.1809462 · 2020-08-31

## TL;DR

Curcumin reduces kidney fibrosis by blocking inflammation and cell transformation through specific signaling pathways.

## Contribution

This study reveals curcumin's novel anti-fibrotic mechanism via TLR4/NF-κB and PI3K/AKT pathway inhibition in renal fibrosis.

## Key findings

- Curcumin improved kidney function and reduced inflammatory markers in mice with obstructive nephropathy.
- Curcumin suppressed epithelial-mesenchymal transition markers in both in vivo and in vitro models.
- Curcumin inhibited TLR4/NF-κB and PI3K/AKT pathways in LPS- and TGF-β1-induced cells.

## Abstract

Renal interstitial fibrosis (RIF) is characterized by the accumulation of inflammatory cytokines and epithelial-mesenchymal transition (EMT). Curcumin exerts antifibrogenic, anti-inflammatory and antiproliferative effects.

To explore the mechanisms underlying the effects of curcumin on RIF.

Eight-week-old male C57BL/6 mice were intragastrically administered curcumin (50 mg/kg/day) for 14 days after undergoing unilateral ureteral obstruction (UUO) operations. Renal function (blood urea nitrogen [BUN] and serum creatinine [Scr]) and inflammatory cytokine levels were tested using colorimetric assays and ELISA, respectively. EMT markers were evaluated through immunohistochemistry, western blotting and qPCR. Transforming growth factor beta 1 (TGF-β1; 10 ng/mL) and lipopolysaccharides (LPS; 100 ng/mL) were used to stimulate EMT and an inflammatory response in human renal proximal tubular epithelial (HK-2) cells, respectively, for further investigation.

In vivo, curcumin significantly improved the levels of BUN and Scr by 28.7% and 21.3%, respectively. Moreover, curcumin reduced the levels of IL-6, IL-1β and TNF-α by 22.5%, 30.3% and 26.7%, respectively, and suppressed vimentin expression in UUO mice. In vitro, curcumin reduced the expression of vimentin and α-smooth muscle actin in TGF-β1-induced HK-2 cells. In LPS-induced HK-2 cells, curcumin decreased the release of IL-6, IL-1β and TNF-α by 43.4%, 38.1% and 28.3%, respectively. In addition, curcumin reduced the expression of TLR4, p-PI3K, p-AKT, p-NF- κB and p-IκBα in both LPS- and TGF-β1-induced HK-2 cells.

Curcumin repressed EMT and the inflammatory response by inhibiting the TLR4/NF-κB and PI3K/AKT pathways, demonstrating its potential utility in RIF treatment.

## Linked entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], TLR4 (toll like receptor 4) [NCBI Gene 7099], Akt (Akt kinase) [NCBI Gene 41957], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446]
- **Proteins:** TGFB1 (transforming growth factor beta 1), TLR4 (toll like receptor 4), Akt (Akt kinase), PRELID1 (PRELI domain containing 1)
- **Chemicals:** curcumin (PubChem CID 969516), IL-6 (PubChem CID 165368475)
- **Diseases:** obstructive nephropathy (MONDO:0056796)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Tlr4 (toll-like receptor 4) [NCBI Gene 29260], Pten (phosphatase and tensin homolog) [NCBI Gene 50557] {aka MMAC1, Mmac, TEP1}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Vim (vimentin) [NCBI Gene 22352], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Keap1 (Kelch-like ECH-associated protein 1) [NCBI Gene 117519] {aka Inrf2}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, VIM (vimentin) [NCBI Gene 7431], MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, Relb (Relb proto-oncogene, NFKB subunit) [NCBI Gene 19698] {aka shep}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Cdh1 (cadherin 1) [NCBI Gene 12550] {aka ARC-1, E-cad, Ecad, L-CAM, UVO, Um}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Rela (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 309165] {aka NFkB, nos2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Rel (Rel proto-oncogene, NFKB subunit) [NCBI Gene 19696] {aka c-Rel}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Nfkb2 (nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100) [NCBI Gene 18034] {aka NF-kappaB2, lyt, p49, p49/p100, p50B, p52}, Met (met proto-oncogene, receptor tyrosine kinase) [NCBI Gene 17295] {aka HGF, HGFR, Par4, c-Met}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Hgf (hepatocyte growth factor) [NCBI Gene 15234] {aka C230052L06Rik, HGF/SF, NK1, NK2, SF, SF/HGF}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 403998], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** tubular injury (MESH:D000230), infection (MESH:D007239), non-alcoholic steatohepatitis (MESH:D005235), hydronephrosis (MESH:D006869), tubulointerstitial collagen (MESH:D009395), inflammation (MESH:D007249), inflammatory cytokines (MESH:D000080424), injury (MESH:D014947), hepatic, pulmonary and renal fibrosis (MESH:D011658), UUO (MESH:D014517), end-stage renal failure (MESH:D007676), neuroinflammatory (MESH:D000090862), cancer (MESH:D009369), obstructive uropathy (MESH:C536483), lung cancer (MESH:D008175), acute pancreatitis (MESH:D010195), RIF (MESH:D005355), Obstructive nephropathy (MESH:D007674),  (MESH:D004195)
- **Chemicals:** penicillin (MESH:D010406), phosphomolybdic acid (MESH:C003125), creatinine (MESH:D003404), LPS (MESH:D008070), Sal (MESH:C009172), eosin (MESH:D004801), paraffin (MESH:D010232), scoparone (MESH:C018145), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), SYBR-Green (MESH:C098022), CO2 (MESH:D002245), haematoxylin (MESH:D006416), LY294002 (MESH:C085911), polyvinylidene difluoride (MESH:C024865), sodium dodecyl sulfate (MESH:D012967), Curcumin (MESH:D003474), TRIzol (MESH:C411644), Cur (-), crocin (MESH:C029036), H&amp;E (MESH:D006371), picroside II (MESH:C416837), hydrogen peroxide (MESH:D006861), isoprenaline (MESH:D007545),  (MESH:D000893)
- **Species:** Curcuma longa (turmeric, species) [taxon 136217], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HKC — Homo sapiens (Human), Transformed cell line (CVCL_WZ51)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7470153/full.md

---
Source: https://tomesphere.com/paper/PMC7470153